成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Shanghai Yifei Biotechnology Co. , Ltd.

Firmenname:Shanghai Yifei Biotechnology Co. , Ltd.
Telefon:021-65675885
E-Mail:customer_service@efebio.com
Nationalit?t:China
URL: http://www.efebio.com
Produkte insgesamt:11974
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

Produktkatalog

Talastine16188-61-7C19H21N3O
UCM-132071621536-10-4
Isolupalbigenin162616-70-8C25H26O5
AC 7739162705-22-8C18H21NO4.ClH
JG-2311627126-59-3C22H18BrCl2N3OS4
Karavilagenin F1639024-15-9C31H50O5
Aprutumab1634620-63-5
Inotuzumab1660159-36-3
Zilovertamab1643432-38-5
Leramistat1642602-54-7C20H21ClN2O3S
Itacnosertib1628870-27-8C26H28N8O
CRT-01059501661845-86-8C21H16ClN3OS
TL4-121620820-12-3C25H27F3N6O2
Ralaniten triacetate1637573-04-6C27H33ClO8
Ranevetmab1632282-27-9
Tavolixizumab1635395-25-3
MAO-B-IN-81638956-60-1C18H16O6
GNE-85051620573-48-9C21H24F3N5O
KZR-5041629052-78-3C21H23N3O6
TASP03903251642187-96-9C25H30Cl2FN5O4
(R)-DNMDP1630760-60-9C15H20N4O3
Ladiratuzumab1629760-28-6
TAK-0201627603-21-7C18H17N5O3
Zectivimod1623066-63-6C28H31Cl2N3O3
Parthenosin166196-16-3C25H26O13
SLMP53-11643469-17-3C20H18N2O2
Naratuximab1622327-39-2
Vonlerolizumab1638935-72-4
Flotetuzumab1664355-28-5
Suvratoxumab1629620-18-3
Tomuzotuximab1646321-00-7
HTL142421644645-32-8C16H8ClFN4
(Rac)-Naxifylline166181-76-6C18H24N4O3
Dalzanemdor1629853-48-0C27H43F3O2
pan-HER-IN-21639040-95-1C19H15BrClN5O
hTYR/AbTYR-IN-11625821-37-5C18H20N2O3
BDBM505974311629853-49-1
Nerelimomab162774-06-3
Dapson-13C121632119-29-9
NDB1660153-08-1C26H28Cl2N2O2
Selicrelumab1622140-49-1
Fluoroethylnormemantine1639210-26-6C12H20FN
ZEN-36941643947-30-1C19H19N5O
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride162045-54-7C12H15ClN2O2
Rivabazumab1627519-84-9
Suptavumab1629615-23-1
Lupartumab1640971-88-5
Relatlimab1673516-98-7
PW04641643462-93-4C19H17F2N3O4
AGN 192870166977-57-7C27H22O2
Azido-PEG3-C6-Cl1625717-44-3
BrBzGCp2166038-00-2C27H38BrN3O6S
L-372662162045-26-3C33H38N4O6
VU04533791638646-27-1C26H34N4O2
PDK1-IN-RS21643958-89-7C15H9ClN2O2S3
Timigutuzumab1665274-14-5
Cipepofol1637741-58-2C14H20O
Nav1.8-IN-41620846-16-3C20H14F4N2O3
DA-68861645260-76-9C19H28Cl2N6O2
Glycopyrronium tosylate1624259-25-1C26H35NO6S
GPR81 agonist 11620992-67-7C22H30N4O2S2
GS-6265101637770-13-8C25H22N4O
Laprituximab1622327-38-1
Frovocimab1643672-70-1
DI-821638148-50-1C20 H26 N6 O4 S3
Osimertinib-d61638281-44-3C28H33N7O2
CT-2584166981-13-1C30H55N5O3
FGFR4-IN-51628793-01-0C23H23Cl2N5O5
ACT-6606021646267-59-5C20H20F6N8OS
DHODH-IN-1716344-26-6C12H9ClN2O2
Eptinezumab1644539-04-7
Fremanezumab1655501-53-3
Otilimab1638332-55-4
Navicixizumab1638338-43-8
TGP-377/42116752-89-9C20H16N6
Vobarilizumab1628814-88-9
FD-IN-11646682-14-5C23H23NO4
Gimsilumab1648796-29-5
CPL3041101627826-19-0C25H30N6O2
RS1-PDK1 inhibitor1643958-85-3C15H9ClN2O2S3
URAT1 inhibitor 71632002-28-8C19H10ClFN4O3S
ABI-19681626364-18-8C35H58N5O6P
Clivatuzumab1622075-09-5
TDRL-5511644626-43-6C25H23ClIN3O4
Gü26021627094-88-5C16H22N4O3
Honokiol DCA1620160-42-0C22H18Cl4O4
Elsubrutinib1643570-24-4C17H19N3O2
Ibiglustat succinate1629063-80-4C24H30FN3O6S
Enrasentan167256-08-8C29H30O8
(Rac)-MEM 1003165187-25-7C22H25ClN2O5
Fluoroethylnormemantine hydrochloride1639210-25-5C12H21ClFN
MLK-IN-11627729-62-7C23H20N4O3S
Talviraline163451-80-7C15H20N2O3S2
GBT11181628799-51-8C19H20N2O4
UniPR1291639159-47-9C36H52N2O4
BTA-98811646857-24-0C21H15ClN4O2
(R)-AZD 96391646857-28-4C21H15ClN4O2
ALDH2 modulator 11629615-99-1C18H18ClFN2O3
(Rac)-Telinavir162679-88-1C33H44N6O5
Delmetacin16401-80-2C18H15NO3
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2019 ? ChemicalBook. All rights reserved